Surmodics reported $-7143000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Align Technology ALGN:US $ 188.2M 9.89M
Anika Therapeutics ANIK:US $ -3.38M 0.17M
Arrowhead Research ARWR:US $ -72909000 114.46M
Baxter International BAX:US $ 351M 188M
Bioscrip BIOS:US $ 59.08M 6.83M
Boston Scientific BSX:US $ 423M 43M
Cryolife CRY:US $ 4.54M 3.38M
Edap Tms EDAP:US $ -0.11M 0.57M
Edwards Lifesciences EW:US $ 459.5M 20.7M
Haemonetics HAE:US $ 30.77M 11.57M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Johnson & Johnson JNJ:US $ 5840M 22M
Merit Medical Systems MMSI:US $ 23.26M 8.02M
Mesa Laboratories MLAB:US $ -4.59M 4.48M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Stryker SYK:US $ 772M 325M
Surmodics SRDX:US $ -7.14M 2.24M
Trinity Biotech TRIB:US $ -10.1M 10.68M